Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Postmenopausal women with unusual hair growth should be checked for ovarian tumors.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Ovarian vein sampling can effectively locate ovarian tumors when imaging is unclear.

Ovarian steroid cell tumors can mimic adrenal hyperplasia, and surgery can normalize hormone levels.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

ADAM17 could be a potential target for treating PCOS.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

An ovarian tumor can cause high male hormones in postmenopausal women.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.